Edwards Lifesciences Corporation To Present At The Bank of America And GARP Research Conferences

IRVINE, Calif., May 12 /PRNewswire-FirstCall/ -- Edwards Lifesciences Corporation , a global leader in medical technologies to treat advanced cardiovascular disease, is scheduled to participate in the Banc of America Health Care Conference 2006 at the Four Seasons Hotel in Las Vegas on May 16th, 2006 at 2:20 p.m. EDT and at the GARP Research 3rd Annual Investor Conference at the InterContinental Harbor Court Hotel in Baltimore on May 17th, 2006 at 9:30 a.m. EDT.

A live webcast of both presentations will be available to all interested parties on the Edwards Lifesciences' investor relations Web site at http://www.edwards.com/InvestorRelations/EventCalendar.htm. An archived version of each webcast will be available later that day on the Edwards' investor relations Web site in the News and Events section.

About Edwards Lifesciences

Edwards Lifesciences, a leader in advanced cardiovascular disease treatments, is the number-one heart valve company in the world and the global leader in acute hemodynamic monitoring. Headquartered in Irvine, Calif., Edwards focuses on specific cardiovascular opportunities including heart valve disease, peripheral vascular disease and critical care technologies. The company's global brands, which are sold in approximately 100 countries, include Carpentier-Edwards, Cosgrove-Edwards, FloTrac, Fogarty, LifeStent, PERIMOUNT and Swan-Ganz. Additional company information can be found at http://www.edwards.com.

Edwards Lifesciences, Edwards, Carpentier-Edwards, Cosgrove-Edwards, Fogarty, PERIMOUNT and Swan-Ganz are trademarks of Edwards Lifesciences Corporation and are registered in the U.S. Patent and Trademark Office. LifeStent is a trademark of Edwards Lifesciences AG and is registered in the U.S. Patent and Trademark Office. FloTrac is a trademark of Edwards Lifesciences Corporation.

Edwards Lifesciences Corporation

CONTACT: Media, Jared B. Adams, +1-949-250-5070, or Investors, David K.Erickson, +1-949-250-6826, both of Edwards Lifesciences Corporation

Back to news